High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
108.05M
+2.46%
0.472
-5.5%
106.53M
+3.86%
0.490
+104.17%
109.00M
-1.21%
0.520
-8.77%
Estimates Revision
The market is revising Downward the revenue expectations for Amerant Bancorp Inc. (AMTB) for FY2025, with the revenue forecasts being adjusted by -0.67% over the past three months. During the same period, the stock price has changed by -9.07%.
Revenue Estimates for FY2025
Revise Downward
-0.67%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
-9.86%
In Past 3 Month
Stock Price
Go Down
-9.07%
In Past 3 Month
3 Analyst Rating
Wall Street analysts forecast AMTB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AMTB is 21.00 USD with a low forecast of 20.00 USD and a high forecast of 22.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 19.350
Low
20.00
Averages
21.00
High
22.00
Current: 19.350
Low
20.00
Averages
21.00
High
22.00
Keefe Bruyette
Market Perform
downgrade
$22 -> $20
2025-11-03
Reason
Keefe Bruyette
Price Target
$22 -> $20
2025-11-03
downgrade
Market Perform
Reason
Keefe Bruyette lowered the firm's price target on Amerant Bancorp to $20 from $22 and keeps a Market Perform rating on the shares.
Raymond James
Market Perform -> Outperform
upgrade
$21
2025-10-29
Reason
Raymond James
Price Target
$21
2025-10-29
upgrade
Market Perform -> Outperform
Reason
Raymond James upgraded Amerant Bancorp to Outperform from Market Perform with a $21 price target. The company reported another "credit-driven" earnings miss in Q3, but management will either fix the credit issues in near-term and right-size its expense base or will unlock shareholder value through a sale of the franchise, the analyst tells investors in a research note. The firm believes "scarcity value" for the unit has increased, creating a host of potential buyers in the event it were to be sold.
Piper Sandler
Overweight
downgrade
$26 -> $22
2025-10-29
Reason
Piper Sandler
Price Target
$26 -> $22
2025-10-29
downgrade
Overweight
Reason
Piper Sandler lowered the firm's price target on Amerant Bancorp to $22 from $26 and keeps an Overweight rating on the shares. The firm says that while the delayed earnings release was as it had feared and was largely the result of a noisy credit quarter, credit was not as bad and could see a bit of a snapback based on some recoveries next quarter. Additionally, Amerant was still able to grow TBVPS by 3.5% quarter-over-quarter, and expects to deliver an 80-90 bps ROA in Q4 2025. Importantly, the bank did announce the early stages of an efficiency initiative and plans to extract $2M-$3M/quarter in cost savings in 2026, Piper adds.
Piper Sandler
Overweight
maintain
$26
2025-10-22
Reason
Piper Sandler
Price Target
$26
2025-10-22
maintain
Overweight
Reason
Piper Sandler keeps an Overweight rating and $26 price target on Amerant Bancorp but notes that the company's announcement to reschedule results is a "somewhat concerning development". There could be a credit hiccup and there is concern this delay could be an indicator of a broader accounting or credit issue, the analyst tells investors in a research note.
Keefe Bruyette
Market Perform
maintain
$20 -> $22
2025-07-28
Reason
Keefe Bruyette
Price Target
$20 -> $22
2025-07-28
maintain
Market Perform
Reason
Keefe Bruyette raised the firm's price target on Amerant Bancorp to $22 from $20 and keeps a Market Perform rating on the shares.
Piper Sandler
Stephen Scouten
Overweight
maintain
$25 -> $26
2025-07-28
Reason
Piper Sandler
Stephen Scouten
Price Target
$25 -> $26
2025-07-28
maintain
Overweight
Reason
Piper Sandler analyst Stephen Scouten raised the firm's price target on Amerant Bancorp to $26 from $25 and keeps an Overweight rating on the shares following quarterly results. The firm notes the company remains focused on delivering a 1% ROA in the second half of 2025, and was pleased to see a slowdown in growth, branch expansions and overall near-term aggressiveness as it works to clean-up the bank. Piper thinks this is a simple story, frankly, and all Amerant needs to do is clean-up credit and grow deposits, so hopefully this newfound patience persists.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Amerant Bancorp Inc (AMTB.N) is 9.43, compared to its 5-year average forward P/E of 12.58. For a more detailed relative valuation and DCF analysis to assess Amerant Bancorp Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Fair
5Y Average PE
12.58
Current PE
9.43
Overvalued PE
16.29
Undervalued PE
8.87
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
2.37
Current PS
0.00
Overvalued PS
3.06
Undervalued PS
1.68
Financials
Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
FCF Margin - %
N/A
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds areSelling! The selling amount has increased 1633.98% over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AMTB News & Events
Events Timeline
(ET)
2025-11-06
07:28:45
Amerant Bancorp's CEO Jerry Plush Resigns; Carlos Iafigliola Appointed Interim CEO
2025-10-28 (ET)
2025-10-28
06:08:41
Amerant Bancorp announces Q3 core EPS of 39 cents, falling short of consensus estimate of 53 cents.
2025-10-22 (ET)
2025-10-22
15:57:40
Amerant Bancorp postpones release of Q3 results
Sign Up For More Events
Sign Up For More Events
News
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/6c33b9f1563b0e2c7476efe58c3e694841f83b9a7c126dd77b019e2a4af8bf1a.jpg)
Preview
5.0
11-06NASDAQ.COMAmerant Bancorp CEO Jerry Plush Steps Down; Carlos Iafigliola Appointed Interim CEO
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/default_image/newsfilter.png)
Preview
9.5
10-23NewsfilterAmerant Bancorp Inc. Announces New Date for Third Quarter 2025 Financial Results and Declares Dividend
Preview
7.5
09-10NewsfilterAMERANT BANK TEAMS UP WITH MIAMI DOLPHINS AND HARD ROCK STADIUM
Sign Up For More News
People Also Watch
FAQ
What is Amerant Bancorp Inc (AMTB) stock price today?
What is Amerant Bancorp Inc (AMTB)'s business?
What is the price predicton of AMTB Stock?
What is Amerant Bancorp Inc (AMTB)'s revenue for the last quarter?
What is Amerant Bancorp Inc (AMTB)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Amerant Bancorp Inc (AMTB)'s fundamentals?
How many employees does Amerant Bancorp Inc (AMTB). have?